However, native GLP-1 has low stability in vivo and is inactivated by the enzyme DPP-4 [34].Two strategies exist for overcoming this problem: first, the development of GLP-1 receptor agonists (GLP-1RAs) that activate GLP-1 receptors similarly to native GLP-1
What happens after my consultation
Federal Lawsuits As of mid-2025, Novo Nordisk has filed more than 130 lawsuits across 40 states against telehealth companies and compounding pharmacies marketing and selling compounded semaglutide
Rafael Olartecoechea at Vive Ageless Weight Loss Center advises that its common to experience some mild side effects, such as nausea or digestive discomfort, which typically subside as the body adjusts
Individuals at risk of AD or with diabetes may be in the early or middle biological stage of AD, offering a greater opportunity for GLP-1RAs to provide neuroprotection
Cheng-Han Chen, a board certified interventional cardiologist and medical director of the Structural Heart Program at MemorialCare Saddleback Medical Center in Laguna Hills, CA, explained to Medical News Today how a diabetes and weight loss drug could help with cardiovascular health